Aggregation of Aβ(1–42) in the presence of short peptides: conformational studies
✍ Scribed by Ilona Laczkó; Elemér Vass; Katalin Soós; Livia Fülöp; Márta Zarándi; Botond Penke
- Book ID
- 105360803
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 475 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1075-2617
- DOI
- 10.1002/psc.990
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
CD and infrared spectroscopic studies were performed on (i) the inhibitory effects of equimolar quantities of LPFFD‐OH and LPYFD‐NH~2~ on the time‐dependent aggregation of amyloid β‐protein (Aβ) (1–42) and (ii) the β‐sheet‐breaker effects of two‐fold molar excess of the pentapeptides on aggregated Aβ(1–42) aged 1 week. The data obtained from the time‐dependent studies demonstrated that LPFFD‐OH did not significantly influence, whereas LPYFD‐NH~2~ exerted some inhibitory effect on the aggregation of Aβ(1–42). When added to a solution of Aβ(1–42) aged 1 week, LPFFD‐OH accelerated, while LPYFD‐NH~2~ delayed, but did not prevent further fibrillogenesis. The difference in the effects of these two pentapeptides on the aggregational profile of Aβ(1–42) is probably due to the difference in their conformational preferences: LPFFD‐OH adopts a β‐turn and extended structures, while LPYFD‐NH~2~ adopts a prevailing β‐turn conformation. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
Alzheimers disease (AD) is the most frequent cause of late-life dementia, with pathological characteristics of extracellular aggregation of amyloid b-peptides (Abs) with 39 ± 43 amino acids, which are proteolytically derived from the transmembrane amyloid precursor protein (APP). [1] Recent studies